These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16215230)

  • 1. Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis.
    Wu ZL; Podust LM; Guengerich FP
    J Biol Chem; 2005 Dec; 280(49):41090-100. PubMed ID: 16215230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.
    Sansen S; Hsu MH; Stout CD; Johnson EF
    Arch Biochem Biophys; 2007 Aug; 464(2):197-206. PubMed ID: 17540336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis.
    Kim D; Wu ZL; Guengerich FP
    J Biol Chem; 2005 Dec; 280(48):40319-27. PubMed ID: 16207711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products.
    Nakamura K; Martin MV; Guengerich FP
    Arch Biochem Biophys; 2001 Nov; 395(1):25-31. PubMed ID: 11673862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6.
    Wu ZL; Aryal P; Lozach O; Meijer L; Guengerich FP
    Chem Biodivers; 2005 Jan; 2(1):51-65. PubMed ID: 17191919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6.
    Yun CH; Kim KH; Calcutt MW; Guengerich FP
    J Biol Chem; 2005 Apr; 280(13):12279-91. PubMed ID: 15665333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acid residues involved in 4-chloroindole 3-hydroxylation by cytochrome P450 2A6 using screening of random libraries.
    Zhang ZG; Liu Y; Guengerich FP; Matse JH; Chen J; Wu ZL
    J Biotechnol; 2009 Jan; 139(1):12-8. PubMed ID: 18984015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis.
    Guengerich FP; Sorrells JL; Schmitt S; Krauser JA; Aryal P; Meijer L
    J Med Chem; 2004 Jun; 47(12):3236-41. PubMed ID: 15163202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of indole by cytochrome P450 enzymes.
    Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
    Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.
    Yano JK; Hsu MH; Griffin KJ; Stout CD; Johnson EF
    Nat Struct Mol Biol; 2005 Sep; 12(9):822-3. PubMed ID: 16086027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydrogenation of indoline by cytochrome P450 enzymes: a novel "aromatase" process.
    Sun H; Ehlhardt WJ; Kulanthaivel P; Lanza DL; Reilly CA; Yost GS
    J Pharmacol Exp Ther; 2007 Aug; 322(2):843-51. PubMed ID: 17502430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directed-evolution analysis of human cytochrome P450 2A6 for enhanced enzymatic catalysis.
    Lee H; Kim JH; Han S; Lim YR; Park HG; Chun YJ; Park SW; Kim D
    J Toxicol Environ Health A; 2014; 77(22-24):1409-18. PubMed ID: 25343290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.
    Daigo S; Takahashi Y; Fujieda M; Ariyoshi N; Yamazaki H; Koizumi W; Tanabe S; Saigenji K; Nagayama S; Ikeda K; Nishioka Y; Kamataki T
    Pharmacogenetics; 2002 Jun; 12(4):299-306. PubMed ID: 12042667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
    Lewis DF; Lake BG
    Xenobiotica; 2002 Jul; 32(7):547-61. PubMed ID: 12162851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 BM-3 evolved by random and saturation mutagenesis as an effective indole-hydroxylating catalyst.
    Li HM; Mei LH; Urlacher VB; Schmid RD
    Appl Biochem Biotechnol; 2008 Jan; 144(1):27-36. PubMed ID: 18415984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
    He XY; Shen J; Hu WY; Ding X; Lu AY; Hong JY
    Arch Biochem Biophys; 2004 Jul; 427(2):143-53. PubMed ID: 15196988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the indigo precursor indican in genetically engineered tobacco plants and cell cultures.
    Warzecha H; Frank A; Peer M; Gillam EM; Guengerich FP; Unger M
    Plant Biotechnol J; 2007 Jan; 5(1):185-91. PubMed ID: 17207267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin Derivatives as Substrate Probes of Mammalian Cytochromes P450 2B4 and 2B6: Assessing the Importance of 7-Alkoxy Chain Length, Halogen Substitution, and Non-Active Site Mutations.
    Liu J; Shah MB; Zhang Q; Stout CD; Halpert JR; Wilderman PR
    Biochemistry; 2016 Apr; 55(13):1997-2007. PubMed ID: 26982502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants.
    Uno T; Obe Y; Ogura C; Goto T; Yamamoto K; Nakamura M; Kanamaru K; Yamagata H; Imaishi H
    Biopharm Drug Dispos; 2013 Mar; 34(2):87-97. PubMed ID: 23112005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.